HDAC6 &Ndash; An Emerging Target Against Chronic Myeloid Leukemia?

doi 10.20944/preprints202001.0030.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells

Stem Cells International
Cell BiologyMolecular Biology
2013English

Chronic Myeloid Leukemia

2020English

Chronic Myeloid Leukemia

Hematologic Malignancies
2016English

Emerging Therapies for Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2017English

Guest Editorial: Chronic Myeloid Leukemia

International Journal of Hematology
Hematology
2018English

Tyrosine Kinase Inhibition: A Therapeutic Target for the Management of Chronic-Phase Chronic Myeloid Leukemia

Expert Review of Anticancer Therapy
OncologyPharmacology
2013English

Autotransplants in Chronic Myeloid Leukemia

Oncologist
Cancer ResearchMedicineOncology
1998English

Immune Control in Chronic Myeloid Leukemia

Oncotarget
Oncology
2017English

A Typical Atypical Chronic Myeloid Leukemia

Clinical Case Reports
Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy